Non-small cell lung cancer stage IIIC

Clinical trials for Non-small cell lung cancer stage IIIC explained in plain language.

Never miss a new study

Get alerted when new Non-small cell lung cancer stage IIIC trials appear

Sign up with your email to follow new studies for Non-small cell lung cancer stage IIIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New test aims to match lung cancer patients with best therapy

Disease control Recruiting now

This phase 2 trial tests whether using a proteomic test (PROphet CB) and a toxicity assessment (CARG-TT) to guide first-line treatment can improve 12-month survival in people with advanced non-small cell lung cancer. About 56 participants will be randomly assigned to receive eith…

Matched conditions: NON-SMALL CELL LUNG CANCER STAGE IIIC

Phase 2 • Sponsor: University of California, Davis • Aim: Disease control

Last updated Aug 27, 2026 00:00 UTC

Non-small cell lung cancer stage IIIC

Get alerted when new Non-small cell lung cancer stage IIIC trials appear

New test aims to match lung cancer patients with best therapy